CHIT1 and metabolic dysfunction-associated steatotic liver disease: Based on clinical research suggesting that CHIT1 indicates the subclinical inflammation in atherosclerosis, non-alcoholic fatty liver disease, and impaired glucose tolerance in animal models and humans (i.e., children and adults) [66,67,68], our findings open a new avenue of biomarkers research in metabolic complications of childhood obesity.